Zentalis Pharmaceuticals, Inc.
ZNTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001725160
In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Zentalis Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 120 | 1 | 116 | −3 |
| Shares | 40.1M | 352.5K | 41.3M | +1.54M (+3.9%) |
| Value | $2.13B | $18.8M | $2.75B | +$636.7M (+30.1%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Zentalis Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ikarian Capital, LLC | 92,344 | $6.15M | 1.41% |
| Ghost Tree Capital, LLC | 65,000 | $4.33M | 1.43% |
| Caption Management, LLC | 35,800 | $2.39M | 0.16% |
| Renaissance Technologies LLC | 31,337 | $2.09M | 0.00% |
| HighVista Strategies LLC | 20,596 | $1.37M | 0.91% |
| Advisory Research Inc | 17,290 | $1.15M | 0.07% |
| Cutler Group LP | 9,050 | $603.0K | 0.05% |
| Cowen and Company, LLC | 6,369 | $424.0K | 0.02% |
| Blueshift Asset Management, LLC | 4,611 | $307.0K | 0.02% |
| Bank of Montreal | 3,489 | $219.0K | 0.00% |
| Teacher Retirement System of Texas | 3,262 | $217.0K | 0.00% |
| Dark Forest Capital Management LP | 1,184 | $79.0K | 0.03% |
| Advisor Group Holdings, Inc. | 103 | $7.00K | 0.00% |
| The PNC Financial Services Group, Inc. | 16 | $2.00K | 0.00% |
| Berman Capital Advisors, LLC | 18 | $1.00K | 0.00% |
Sold out (18)
Institutions that held Zentalis Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Redmile Group, LLC | 425,480 | $22.6M |
| EcoR1 Capital, LLC | 200,000 | $10.6M |
| Pura Vida Investments, LLC | 91,069 | $4.84M |
| Caas Capital Management LP | 50,000 | $2.66M |
| Monashee Investment Management LLC | 44,905 | $2.39M |
| Pinz Capital Management, LP | 35,903 | $1.91M |
| Millennium Management LLC | 26,368 | $1.40M |
| Squarepoint Ops LLC | 19,577 | $1.04M |
| Alpha Paradigm Partners, LLC | 13,523 | $719.0K |
| Copernicus Capital Management, LLC | 10,000 | $532.0K |
| Quantitative Systematic Strategies LLC | 6,930 | $369.0K |
| Trexquant Investment LP | 5,969 | $318.0K |
| Paloma Partners Management Co | 5,411 | $288.0K |
| ExodusPoint Capital Management, LP | 5,300 | $282.0K |
| Point72 Hong Kong Ltd | 4,422 | $235.0K |
| FORA Capital, LLC | 2,692 | $143.0K |
| Quantbot Technologies LP | 103 | $5.00K |
| Signaturefd, LLC | 16 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Zentalis Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Mayo Clinic | 352,459 | $18.8M |